HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.

Abstract
The potential of nontoxic recombinant B subunits of cholera toxin (rCtxB) and its close relative Escherichia coli heat-labile enterotoxin (rEtxB) to act as mucosal adjuvants for intranasal immunization with herpes simplex virus type 1 (HSV-1) glycoproteins was assessed. Doses of 10 microg of rEtxB or above with 10 microg of HSV-1 glycoproteins elicited high serum and mucosal anti-HSV-1 titers comparable with that obtained using CtxB (10 microg) with a trace (0.5 microg) of whole toxin (Ctx-CtxB). By contrast, doses of rCtxB up to 100 microg elicited only meager anti-HSV-1 responses. As for Ctx-CtxB, rEtxB resulted in a Th2-biased immune response with high immunoglobulin G1 (IgG1)/IgG2a antibody ratios and production of interleukin 4 (IL-4) and IL-10 as well as gamma interferon by proliferating T cells. The protective efficacy of the immune response induced using rEtxB as an adjuvant was assessed following ocular challenge of immunized and mock-immunized mice. Epithelial disease was observed in both groups, but the immunized mice recovered by day 6 whereas mock-immunized mice developed more severe corneal disease leading to stromal keratitis. In addition, a significant reduction in the incidence of lid disease and zosteriform spread was observed in immunized animals and there was no encephalitis compared with 95% encephalitis in mock-immunized mice. The potential of such mucosal adjuvants for use in human vaccines against pathogens such as HSV-1 is discussed.
AuthorsC M Richards, A T Aman, T R Hirst, T J Hill, N A Williams
JournalJournal of virology (J Virol) Vol. 75 Issue 4 Pg. 1664-71 (Feb 2001) ISSN: 0022-538X [Print] United States
PMID11160664 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Viral
  • Bacterial Toxins
  • Enterotoxins
  • Escherichia coli Proteins
  • Recombinant Proteins
  • Viral Envelope Proteins
  • Cholera Toxin
  • heat-labile enterotoxin, E coli
Topics
  • Adjuvants, Immunologic
  • Administration, Intranasal
  • Animals
  • Antibodies, Viral (blood)
  • Bacterial Toxins (genetics, immunology)
  • Cholera Toxin (genetics, immunology)
  • Enterotoxins (genetics, immunology)
  • Escherichia coli (metabolism)
  • Escherichia coli Proteins
  • Female
  • Herpesvirus 1, Human (immunology)
  • Immunity, Mucosal
  • Immunization
  • Keratitis, Herpetic (immunology)
  • Mice
  • Recombinant Proteins (immunology)
  • Viral Envelope Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: